 |
May 4, 2006
N-Glycanase® Patent Maintained in Europe
European Patent No. 0 472 651 in the name of Genzyme Corporation
with opposition by Roche Diagnostics GmbH was maintained in oral proceedings
before the Technical Board of Appeals.
See here a copy of the preliminary
minutes.
See the full minutes.
N-Glycanase® is a registered trademark of Genzyme
Corporation, Boston, MA, USA. Recombinant PNGase F is covered by
US Patent No 5,238,821 and EP Patent No 0472651 B1, which are exclusively
licensed for manufacture by ProZyme, Inc.
|
